We can't find the internet
Attempting to reconnect
18283.1 PFLS-LS
18283.1 PFLS-LS
Zusammenfassung
Adenosine A2A receptor positive allosteric modulators (PAM) as a novel broadly applicable oral anti-inflammatory therapy
Weitere Texte
Abstract
||||||To discover first-in-class selective small molecule A2AR PAM as a novel oral anti-inflammatory therapy. Because it preserves the natural spatio-temporal control over A2AR engagement, an A2AR PAM would avoid side effects relating to systemic triggering of A2AR and present distinct advantages over straight agonists by selectively enhancing the well-validated anti-inflammatory effects of high adenosine concentration only within inflamed tissues|||||||
Beteiligte
Luc Otten
Wirtschaftspartner
luc.otten@aidd.ch
AIDD Luc Otten Bâtiment C / EPFL Innovation Park 1015 Lausanne VD CH
Leonardo Scapozza
Kontaktperson
leonardo.scapozza@unige.ch
Université de Genève Leonardo Scapozza Quai Ernest-Ansermet 30 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2017-01-31
- Bewilligte Gesamtkosten
- CHF 194256.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%